X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (71819) 71819
Publication (4471) 4471
Patent (1429) 1429
Newsletter (1340) 1340
Magazine Article (1274) 1274
Book Review (884) 884
Book Chapter (619) 619
Newspaper Article (547) 547
Conference Proceeding (452) 452
Dissertation (218) 218
Trade Publication Article (106) 106
Book / eBook (39) 39
Web Resource (27) 27
Reference (16) 16
Market Research (12) 12
Paper (11) 11
Transcript (10) 10
Data Set (8) 8
Government Document (7) 7
Journal / eJournal (4) 4
Presentation (2) 2
Streaming Video (2) 2
Magazine (1) 1
Microfilm (1) 1
Standard (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41216) 41216
male (24886) 24886
animals (20083) 20083
female (18390) 18390
angiotensin-converting enzyme inhibitors - therapeutic use (18319) 18319
index medicus (15939) 15939
middle aged (12845) 12845
hypertension (10791) 10791
aged (10533) 10533
rats (9890) 9890
hypertension - drug therapy (9552) 9552
angiotensin-converting enzyme (9033) 9033
cardiac & cardiovascular systems (8922) 8922
angiotensin-converting enzyme inhibitors - pharmacology (8766) 8766
adult (8748) 8748
pharmacology & pharmacy (8100) 8100
angiotensin (7876) 7876
peripheral vascular disease (7323) 7323
blood pressure - drug effects (7169) 7169
angiotensin converting enzyme (5780) 5780
risk factors (5713) 5713
antihypertensive agents - therapeutic use (5668) 5668
blood-pressure (5584) 5584
angiotensin-converting enzyme inhibitors (5131) 5131
heart failure - drug therapy (4681) 4681
treatment outcome (4586) 4586
medicine, general & internal (4486) 4486
captopril (4370) 4370
biochemistry & molecular biology (4333) 4333
renin-angiotensin system (4319) 4319
hypertension - physiopathology (4238) 4238
blood pressure (4181) 4181
heart failure (4176) 4176
mortality (4160) 4160
urology & nephrology (4121) 4121
enzymes (4117) 4117
angiotensin-converting enzyme inhibitors - adverse effects (3974) 3974
adrenergic beta-antagonists - therapeutic use (3907) 3907
drug therapy, combination (3855) 3855
research (3725) 3725
renin-angiotensin system - drug effects (3690) 3690
angiotensin-converting enzyme inhibitors - administration & dosage (3669) 3669
ace inhibitors (3642) 3642
mice (3486) 3486
time factors (3333) 3333
myocardial-infarction (3329) 3329
converting enzyme-inhibitors (3233) 3233
converting enzyme-inhibition (3169) 3169
analysis (3155) 3155
enalapril (3137) 3137
expression (3007) 3007
peptidyl-dipeptidase a - genetics (2821) 2821
angiotensin ii (2743) 2743
hypertension - complications (2710) 2710
aged, 80 and over (2700) 2700
calcium channel blockers - therapeutic use (2644) 2644
converting (2625) 2625
physiology (2623) 2623
disease (2621) 2621
converting enzyme (2596) 2596
peptidyl-dipeptidase a - metabolism (2596) 2596
renin-angiotensin system - physiology (2539) 2539
angiotensin receptor antagonists (2513) 2513
dose-response relationship, drug (2501) 2501
captopril - pharmacology (2439) 2439
drug therapy (2424) 2424
rats, sprague-dawley (2364) 2364
risk (2349) 2349
physiological aspects (2334) 2334
antihypertensive agents - pharmacology (2330) 2330
diuretics - therapeutic use (2320) 2320
double-blind method (2317) 2317
heart-failure (2308) 2308
system (2278) 2278
angiotensin ii type 1 receptor blockers - therapeutic use (2268) 2268
care and treatment (2261) 2261
diabetes (2254) 2254
health aspects (2254) 2254
therapy (2220) 2220
endocrinology & metabolism (2181) 2181
heart failure - physiopathology (2179) 2179
prognosis (2095) 2095
renin (2082) 2082
bradykinin (2071) 2071
medicine, research & experimental (2063) 2063
cell biology (2054) 2054
follow-up studies (2048) 2048
rats, wistar (2034) 2034
medicine & public health (1947) 1947
genotype (1945) 1945
inhibition (1942) 1942
disease models, animal (1934) 1934
converting-enzyme (1914) 1914
prospective studies (1904) 1904
angiotensin-ii (1877) 1877
peptides (1868) 1868
polymorphism, genetic (1864) 1864
enalapril - therapeutic use (1853) 1853
apoptosis (1834) 1834
retrospective studies (1834) 1834
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (21) 21
Online Resources - Online (15) 15
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Engineering & Comp. Sci. - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Periodical Stacks (1) 1
Media Commons - Microtexts (1) 1
Scarborough Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (69199) 69199
Dutch (1497) 1497
German (1330) 1330
French (997) 997
Russian (894) 894
Japanese (887) 887
Spanish (616) 616
Chinese (591) 591
Italian (269) 269
Polish (254) 254
Portuguese (147) 147
Korean (140) 140
Czech (90) 90
Hungarian (89) 89
Danish (84) 84
Swedish (62) 62
Norwegian (56) 56
Turkish (36) 36
Finnish (30) 30
Slovak (30) 30
Romanian (28) 28
Ukrainian (23) 23
Hebrew (22) 22
Serbian (19) 19
Croatian (17) 17
Lithuanian (17) 17
Persian (10) 10
Bosnian (4) 4
Bulgarian (4) 4
Slovenian (4) 4
Indonesian (2) 2
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, ISBN 9781402047930, x, 157
Convertases are widely expressed activating enzymes involved in various physiological and pathological processes. This book provides detailed and updated... 
Enzyme inhibitors | Treatment | Genetic aspects | Carcinogenesis | Molecular aspects | Therapeutic use | Cancer | Cancer Research | Oncology | Biomedicine | Chemistry/Food Science, general
Book
Composites Science and Technology, ISSN 0266-3538, 12/2013, Volume 89, pp. 211 - 225
The article describes the concept of converting instead of adding used for preparation of the two new polymer materials, namely, the nano/microfibrillar... 
Converting
Journal Article
2001, Milestones in drug therapy., ISBN 376435982X, x, 187
Book
Computer Measurement & Control, ISSN 1671-4598, 09/2013, Volume 21, Issue 9, pp. 2372 - 2374
Fault tree is usually graphic stored. Although it could reflect the relationships among fault events, the fault diagnosis expert system could not use it... 
Converting
Journal Article
Journal Article
Science of Surveying and Mapping, ISSN 1009-2307, 09/2013, Volume 38, Issue 5, pp. 141 - 145
The department of China's maritime mapping has brought CARIS HPD hydrographic product database system since 2008. Its spatial data is difficult to be... 
Converting
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 993 - 1004
Journal Article
Research in Veterinary Science, ISSN 0034-5288, 10/2017, Volume 114, pp. 117 - 122
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 1, pp. 40 - 51
This study aimed to determine whether early administration of drugs that block the renin–angiotensin system slows the progression of change in glomerular... 
CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | STRUCTURAL-FUNCTIONAL RELATIONSHIPS | CORTICAL INTERSTITIUM | BLOOD-PRESSURE CONTROL | EARLY NATURAL-HISTORY | RETINOPATHY | ANGIOTENSIN-CONVERTING ENZYME | NEPHROPATHY | PROGRESSION | ENDOTHELIAL GROWTH-FACTOR | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article